ID

36380

Beschrijving

A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02); ODM derived from: https://clinicaltrials.gov/show/NCT01989676

Link

https://clinicaltrials.gov/show/NCT01989676

Trefwoorden

Versies (1)
  1. 08-05-19 08-05-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

8 mei 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Metastatic Breast Cancer NCT01989676

Engels

Eligibility Metastatic Breast Cancer NCT01989676

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed diagnosis of breast cancer.
Beschrijving

Breast Carcinoma

Datatype

boolean

Alias
UMLS CUI [1]
C0678222
presence of metastatic disease.
Beschrijving

Neoplasm Metastasis

Datatype

boolean

Alias
UMLS CUI [1]
C0027627
documentation of her2 gene amplification or overexpression.
Beschrijving

HER2 gene amplification | HER2 Protein Overexpression

Datatype

boolean

Alias
UMLS CUI [1]
C1512127
UMLS CUI [2]
C1515560
available tumor tissue for central review of her2 status.
Beschrijving

Tumor tissue sample Available | Review of HER2 Status

Datatype

boolean

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C0470187
UMLS CUI [2,1]
C0699752
UMLS CUI [2,2]
C1512413
at least 1 measurable lesion as defined by recist 1.1.
Beschrijving

Measurable lesion Quantity

Datatype

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
eastern cooperative oncology group status of 0 to 2.
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
left ventricular ejection fraction within institutional range of normal, measured by either two dimensional echocardiogram or multigated acquisition scan.
Beschrijving

Left ventricular ejection fraction Within reference range Echocardiography 2-Dimensional | Left ventricular ejection fraction Within reference range MUGA scan

Datatype

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C0460094
UMLS CUI [1,3]
C0013516
UMLS CUI [1,4]
C1705052
UMLS CUI [2,1]
C0428772
UMLS CUI [2,2]
C0460094
UMLS CUI [2,3]
C0521317
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
relapse within 1 year of last dose of previous adjuvant (including neoadjuvant) treatment (except endocrine therapy).
Beschrijving

Recurrent disease | Adjuvant therapy | Neoadjuvant Therapy | Exception Hormone Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2]
C0677850
UMLS CUI [3]
C0600558
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0279025
prior systemic therapy for metastatic disease (except endocrine therapy).
Beschrijving

Systemic therapy Neoplasm Metastasis | Exception Hormone Therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0027627
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0279025
prior cumulative dose of doxorubicin of >400 mg/m2, epirubicin dose >800 mg/m^2, or the equivalent dose for other anthracyclines or derivatives (eg, 72 mg/m^2 of mitoxantrone). if the patient has received more than one anthracycline, then the cumulative dose must not exceed the equivalent of 400 mg/m^2 of doxorubicin.
Beschrijving

Doxorubicin Cumulative Dose | Epirubicin Dose | Anthracyclines Dose Equivalent | Derivative Dose Equivalent | Mitoxantrone Dose

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C2986497
UMLS CUI [2,1]
C0014582
UMLS CUI [2,2]
C0178602
UMLS CUI [3,1]
C0282564
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205163
UMLS CUI [4,1]
C1527240
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205163
UMLS CUI [5,1]
C0026259
UMLS CUI [5,2]
C0178602
inflammatory breast cancer.
Beschrijving

Inflammatory Breast Carcinoma

Datatype

boolean

Alias
UMLS CUI [1]
C0278601
active uncontrolled or symptomatic central nervous system metastases.
Beschrijving

CNS metastases Uncontrolled | CNS metastases Symptomatic

Datatype

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0686377
UMLS CUI [2,2]
C0231220
Terug naar het begin van de pagina

Similar models

Eligibility Metastatic Breast Cancer NCT01989676

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma
Item
histologically confirmed diagnosis of breast cancer.
boolean
C0678222 (UMLS CUI [1])
Neoplasm Metastasis
Item
presence of metastatic disease.
boolean
C0027627 (UMLS CUI [1])
HER2 gene amplification | HER2 Protein Overexpression
Item
documentation of her2 gene amplification or overexpression.
boolean
C1512127 (UMLS CUI [1])
C1515560 (UMLS CUI [2])
Tumor tissue sample Available | Review of HER2 Status
Item
available tumor tissue for central review of her2 status.
boolean
C0475358 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C0699752 (UMLS CUI [2,1])
C1512413 (UMLS CUI [2,2])
Measurable lesion Quantity
Item
at least 1 measurable lesion as defined by recist 1.1.
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
eastern cooperative oncology group status of 0 to 2.
boolean
C1520224 (UMLS CUI [1])
Left ventricular ejection fraction Within reference range Echocardiography 2-Dimensional | Left ventricular ejection fraction Within reference range MUGA scan
Item
left ventricular ejection fraction within institutional range of normal, measured by either two dimensional echocardiogram or multigated acquisition scan.
boolean
C0428772 (UMLS CUI [1,1])
C0460094 (UMLS CUI [1,2])
C0013516 (UMLS CUI [1,3])
C1705052 (UMLS CUI [1,4])
C0428772 (UMLS CUI [2,1])
C0460094 (UMLS CUI [2,2])
C0521317 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Recurrent disease | Adjuvant therapy | Neoadjuvant Therapy | Exception Hormone Therapy
Item
relapse within 1 year of last dose of previous adjuvant (including neoadjuvant) treatment (except endocrine therapy).
boolean
C0277556 (UMLS CUI [1])
C0677850 (UMLS CUI [2])
C0600558 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0279025 (UMLS CUI [4,2])
Systemic therapy Neoplasm Metastasis | Exception Hormone Therapy
Item
prior systemic therapy for metastatic disease (except endocrine therapy).
boolean
C1515119 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
Doxorubicin Cumulative Dose | Epirubicin Dose | Anthracyclines Dose Equivalent | Derivative Dose Equivalent | Mitoxantrone Dose
Item
prior cumulative dose of doxorubicin of >400 mg/m2, epirubicin dose >800 mg/m^2, or the equivalent dose for other anthracyclines or derivatives (eg, 72 mg/m^2 of mitoxantrone). if the patient has received more than one anthracycline, then the cumulative dose must not exceed the equivalent of 400 mg/m^2 of doxorubicin.
boolean
C0013089 (UMLS CUI [1,1])
C2986497 (UMLS CUI [1,2])
C0014582 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0282564 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205163 (UMLS CUI [3,3])
C1527240 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205163 (UMLS CUI [4,3])
C0026259 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
Inflammatory Breast Carcinoma
Item
inflammatory breast cancer.
boolean
C0278601 (UMLS CUI [1])
CNS metastases Uncontrolled | CNS metastases Symptomatic
Item
active uncontrolled or symptomatic central nervous system metastases.
boolean
C0686377 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0686377 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial